* Core Laboratories NV CLB.N reported quarterly adjusted
earnings of 18 cents per share for the quarter ended in
September. The mean expectation of eleven analysts for the
quarter was for earnings of 19 cents per share.
* Revenue rose 12% to $117.99 million from a year ago; analysts
expected $122.63 million.
* Core Laboratories NV's reported EPS for the quarter was 2
cents.
* The mean earnings estimate of analysts had fallen by
about 20.8% in the last three months.
* In the last 30 days two analysts negatively revised earnings
estimates
* Core Laboratories NV shares had fallen by 0.3% this
quarter and gained 4.3% so far this year.
* The company reported quarterly net income of $874 thousand.
* Wall Street's median 12-month price target for Core
Laboratories NV is $31.00
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 3 "strong buy" or "buy," 6
"hold" and 2 "sell" or "strong sell."
This summary was machine generated October 27 at 11:03 p.m.
All figures in US dollars unless otherwise stated